Drug Discovery Biology

Uncovering the secrets of the human body to drive drug discovery

About us

Find out more about the Drug Discovery Biology theme.

Research labs

Our research groups are supported by government grant schemes and key industry partnerships, and collaborate extensively with national and international researchers.

Therapeutic areas

Learn about the five therapeutic areas that underpin the focus of our research.

PhD program

Discover what a higher degree with us entails and find out about available projects.

Research capabilities

Learn more about the techniques we employ.

Contact us

For any enquiries please contact +61 3 9903 9614 or pharm-ddbenquiries@monash.edu.

Latest news from DDB

AC, CV & NT

Monash researchers awarded up to $22.4 Million AUD to develop new medicines for restoring lymphatic pumping

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop medicines restoring lymphatic vessel function, backed by up to $22.4 million AUD from ARPA-H.
12 March, 2026 Research
Halls and Ellisdon

Australian scientists solve enduring mystery about diseases driven by uncontrolled cell growth, including cancer and epilepsy

Scientists discover a partnership of proteins called the “KICSTOR–GATOR1 complex” that operate as a control system inside our cells, telling them when to grow and when to stop based on nutrient availability (especially amino acids).
9 January, 2026 Research
Arthur Christopoulos and Patrick Sexton

Monash scientists recognised among global top one per cent for pharmacology and toxicology

Professor Arthur Christopoulos and Professor Patrick Sexton have been identified among the top one per cent of international scientists for their field in the 2025 list of Clarivate Highly Cited Researchers.
13 November, 2025 Research
Mark, Kristian, Nimna and Martin

MIPS researchers secure ARC Funding for research into healthy ageing and sustainable materials for drug delivery

MIPS researchers, Professor Mark Febbraio, Dr Nimna Perera, Dr Martin Whitham and Associate Professor Kristian Kempe, secure Australian Research Council (ARC) Funding.
29 October, 2025 Research
New study reveals potential ‘two-in-one’ treatment for diabetes and heart disease

New study reveals potential ‘two-in-one’ treatment for diabetes and heart disease

Building on earlier studies showing its benefits for type 2 diabetes, new study has revealed experimental drug ‘IC7Fc’ may help prevent heart disease by lowering cholesterol and reducing inflammation.
28 October, 2025 Research

MIPS early-career researchers awarded the 2025 Ian Fehring Innovation Seed Grant

MIPS researchers, Dr Annaliese Dillon and Dr Anida Velagic, have been awarded the 2025 Ian Fehring Innovation Seed Grant, an initiative of the Victorian Heart Institute (VHI).
28 October, 2025 Research
A tenebrosa_Pete

Monash University joins national effort to decode and harness venoms for science and innovation

Researchers from MIPS are among the team supporting the newly established Australian Venom Innovation and Discovery (AVID) Initiative.
1 October, 2025 Research

New discovery: ‘Switching off’ enzyme prevents diet-induced obesity, other metabolic diseases

An international team led by Monash University and Baylor College of Medicine found that CaMKK2 in immune cells can drive inflammation, preventing diet-induced obesity, diabetes and fatty liver disease.
24 September, 2025 Research

New study uncovers how beta blockers could halt the progression of triple negative breast cancer

Researchers have identified a molecular biomarker in triple negative breast cancer tumours which could inform when beta blockers can play a role in “switching off” tumour progression.
20 August, 2025 Research

Other research themes